AICDA

Chr 12AR

activation induced cytidine deaminase

Also known as: AID, ARP2, CDA2, HEL-S-284, HIGM2

This gene encodes a single-stranded DNA cytidine deaminase that is essential for somatic hypermutation, gene conversion, and class-switch recombination of immunoglobulin genes in germinal center B cells. Mutations cause autosomal recessive immunodeficiency with hyper-IgM type 2, characterized by defective antibody class switching and impaired humoral immune responses. The gene shows low constraint to loss-of-function variation (pLI near 0), consistent with its autosomal recessive inheritance pattern.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Immunodeficiency with hyper-IgM, type 2MIM #605258
AR
0
Active trials
13
Pubs (1 yr)
14
P/LP submissions
17%
P/LP missense
1.33
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryAICDA
🧬
Gene-Disease Validity (ClinGen)
hyper-IgM syndrome type 2 · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
12 unique Pathogenic / Likely Pathogenic· 39 VUS of 100 total submissions
📖
GeneReview available — AICDA
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.33LOEUF
pLI 0.000
Z-score 0.75
OE 0.76 (0.461.33)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
1.34Z-score
OE missense 0.67 (0.570.80)
89 obs / 132.3 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.76 (0.461.33)
00.351.4
Missense OE0.67 (0.570.80)
00.61.4
Synonymous OE1.23
01.21.6
LoF obs/exp: 9 / 11.8Missense obs/exp: 89 / 132.3Syn Z: -1.23
DN
0.7229th %ile
GOF
0.73top 25%
LOF
0.2485th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

100 submitted variants in ClinVar

Classification Summary

Pathogenic7
Likely Pathogenic5
VUS39
Likely Benign43
Benign6
7
Pathogenic
5
Likely Pathogenic
39
VUS
43
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
7
0
7
Likely Pathogenic
2
2
1
0
5
VUS
2
32
5
0
39
Likely Benign
1
0
23
19
43
Benign
0
0
6
0
6
Total5344219100

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

AICDA · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →